SCHEMBL14907902

SCHEMBL14907902

Nc1ccccc1CCNC(=S)NCc1ccnc2[nH]ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
MTNR1A P48039 2/20 0.37
PRKCI P41743 3/20 0.36
AXL P30530 1/20 0.36
IKBKB O14920 1/20 0.36
CHUK O15111 1/20 0.36
DAPK3 O43293 1/20 0.36
JAK2 O60674 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
PAK4 O96013 1/20 0.36
CSF1R P07333 1/20 0.36
RET P07949 1/20 0.36
IGF1R P08069 1/20 0.36
FGFR1 P11362 1/20 0.36
PRKACA P17612 1/20 0.36
FLT1 P17948 1/20 0.36
LTK P29376 1/20 0.36
GRK5 P34947 1/20 0.36
KDR P35968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14894258 0.92 JAK2 (0.40) PRKCIAXLIKBKBCHUKDAPK3
SCHEMBL14894265 0.83 PRKCI (0.40) LMNAPRKCIAXLIKBKBCHUK
SCHEMBL14907843 0.82 IKBKB (0.40) PRKCIAXLIKBKBCHUKDAPK3
SCHEMBL14907663 0.82 AKT1 (0.44) PRKCIAXLIKBKBCHUKDAPK3
SCHEMBL14894261 0.80 MEN1 (0.51) LMNAPRKCIAXLJAK2NPC1
SCHEMBL14907651 0.80 AKT1 (0.38) PRKCIAXLIKBKBCHUKDAPK3
SCHEMBL14907989 0.79 AKT1 (0.38) PRKCIAXLIKBKBCHUKDAPK3
SCHEMBL14894364 0.79 PTPN1 (0.39) LMNAMTNR1AJAK2RETFGFR1
SCHEMBL14894374 0.76 PRKCI (0.55) PRKCIAXLIKBKBCHUKDAPK3
SCHEMBL14907813 0.76 NUDT1 (0.40) LMNAPRKCIAXLJAK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9174984-B2 Chemical compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-11-03 US disclosed
US-20140296204-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2014-10-02 US disclosed
WO-2013062945-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296204-A1 CHEMICAL COMPOUNDS DNMT1, DNMT3A, DNMT3B LMNA 1670/4885MTNR1A 1326/4885PRKCI 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.